86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04266197 (ClinicalTrials.gov)	September 25, 2020	22/1/2020	Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study	A Phase 2b, Open-label, Single Dose Study to Evaluated the Safety and Efficacy of RT234 on Exercise ...	Pulmonary Arterial Hypertension	Combination Product:Drug: RT234 - vardenafilinhalation powder; Device: Axially Oscillating Sphere dr ...	Respira Therapeutics, Inc.	NULL	Recruiting	18 Years	80 Years	All	86	Phase 2	United States;Serbia
2	NCT05343637 (ClinicalTrials.gov)	July 30, 2019	4/4/2022	A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hyperten ...	A Phase 2a, Dose Escalation Study to Evaluate the Effect of RT234 on Cardiopulmonary Hemodynamics in ...	Pulmonary Arterial Hypertension	Combination Product:Drug: RT234 - vardenafilinhalation powder; Device: RS01 dry powder inhaler (RS01 ...	Respira Therapeutics, Inc.	NULL	Completed	18 Years	80 Years	All	14	Phase 2	Australia
3	NCT01649739 (ClinicalTrials.gov)	September 2012	22/7/2012	Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost		Pulmonary Arterial Hypertension	Drug: Levitra	Rabin Medical Center	NULL	Not yet recruiting	18 Years	70 Years	Both	20	Phase 4	Israel
4	NCT00705588 (ClinicalTrials.gov)	August 2008	25/6/2008	Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertensio ...		Pulmonary Arterial Hypertension	Drug: Tadalafil;Drug: Vardenafil	Rabin Medical Center	NULL	Not yet recruiting	18 Years	N/A	Both	30	Phase 4	Israel
5	NCT00718952 (ClinicalTrials.gov)	July 2008	18/7/2008	The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension	Multi-centre, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Treatm ...	Pulmonary Hypertension	Drug: Vardenafil;Drug: Placebo	Tongji University	NULL	Completed	12 Years	65 Years	Both	60	Phase 3	China

First Previous1Next Last